
Creekside Family Practice Reports 90% Online Appointment Scheduling with eClinicalWorks EHR and healow
eClinicalWorks®, the leading provider of cloud-based EHR systems, has announced that Creekside Family Practice is effectively using eClinicalWorks EHR and healow® Open Access® for online appointment scheduling. The practice has reported that 90% of their monthly appointments are scheduled through…

Forge Health Set for Growth with MFO Ventures Investment
Forge Health, a top provider of outpatient mental health and substance use care, has secured a strategic growth investment from MFO Ventures. This funding will support the optimization and expansion of Forge Health’s platform, focusing on nationwide virtual care integration,…

Guardant Health to Ring Nasdaq Bell on August 28 for Shield™ Colorectal Cancer Test Launch
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology firm, will ring the Nasdaq opening bell at MarketSite in Times Square, New York on Wednesday, August 28, 2024. “Today, we celebrate the launch of Shield, our FDA-approved blood-based test for…

Simulations Plus Restructures Business Units to Support Growth After Recent Acquisitions
Simulations Plus, Inc. (Nasdaq: SLP), a top provider of biosimulation, simulation-enabled performance, intelligence solutions, and medical communications for the biopharma industry, has announced an optimization of its business unit and leadership structure. This strategic move, effective August 30, 2024, is…

bluebird bio Receives Expected Nasdaq Notices
bluebird bio, Inc. (Nasdaq: BLUE) announced on August 20, 2024, that it received notices from Nasdaq stating it is not in compliance with Nasdaq Listing Rule 5250(c)(1). This is due to the company’s failure to file its Quarterly Reports on…

BeMe Health Joins Hesperia Capital’s Portfolio with $12.5M in New Funding
BeMe Health, an innovator in digital behavioral health for teens, has secured over $12 million in new funding, marking a significant milestone ahead of its upcoming Series A round. This latest investment, which makes BeMe Health the newest addition to…

ADVI Health Acquires Partnership for Health Analytic Research
ADVI Health is excited to announce the acquisition of Partnership for Health Analytic Research (PHAR), a leading global consultancy specializing in health technology assessment (HTA) and health economics and outcomes research (HEOR). PHAR is renowned for delivering impactful, data-driven insights…

SurGenTec’s B-MAN Bone Marrow Kit with Filtration Gains FDA Clearance
SurGenTec, a leader in orthopedic and spine technology, is excited to announce that its proprietary B-MAN Bone Marrow Aspirate Kit has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). The B-MAN Kit revolutionizes bone marrow aspiration by…

Techstars, Johns Hopkins, and CareFirst Launch Healthcare AI Accelerator in Baltimore
Techstars, Johns Hopkins University, and CareFirst BlueCross BlueShield (CareFirst) have announced a new collaboration to launch a healthcare accelerator program. This initiative aims to support early-stage entrepreneurs developing AI-driven solutions for improving care pathways. Techstars AI Health Baltimore, powered by…

Invenra’s Antibody INV724 Gains FDA Rare Pediatric and Orphan Drug Designations for Neuroblastoma
Invenra Inc. is excited to announce that its innovative bispecific antibody, INV724, designed for the treatment of neuroblastoma, has received both Rare Pediatric Disease (RPDD) and Orphan Drug (ODD) Designations from the U.S. Food and Drug Administration (FDA). These designations…

VION Biosciences Acquires Echelon Biosciences, a Leader in Specialty Lipids and Nanoparticles
VION Biosciences, a life science platform company specializing in specialty reagents for research, diagnostics, and drug discovery, has announced the acquisition of Echelon Biosciences, a Salt Lake City-based supplier known for its critical materials, including lipid-based excipients. This acquisition marks…

FDA Clears AISAP’s CARDIO AI Ultrasound Diagnostic Software
AISAP, a medical technology company focused on AI-powered Point-of-Care Assisted Diagnosis (POCAD™) solutions, has received 510(k) clearance from the U.S. FDA for its innovative AISAP CARDIO software platform. This cloud-based, AI-powered tool is designed for point-of-care ultrasound (POCUS) and integrates…
